Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis

BACKGROUND. The survival benefit of combining sorafenib and transarterial chemoembolization (TACE) therapy compared with sorafenib monotherapy for patients with advanced hepatocellular carcinoma (HCC) and main portal vein tumor thrombosis (MPVTT) is unclear. METHODS. Between January 2009 and June 20...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncologist
Hauptverfasser: Zhang, Yingqiang, Fan, Wenzhe, Wang, Yu, Lu, Ligong, Fu, Sirui, Yang, Jianyong, Huang, Yonghui, Yao, Wang, Li, Jiaping
Format: Artigo
Sprache:Inglês
Veröffentlicht: AlphaMed Press 2015
Schlagworte:
Hepatobiliary
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4679083/
https://ncbi.nlm.nih.gov/pubmed/26446238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0196
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge